Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: Essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

Nephrology Dialysis Transplantation

Volumn 13, Issue 1, 1998, Pages 213-221

  Lamprecht, P ^a,b   Schmitt, W H ^a   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Medizinische Krankenhausabteilung   (Germany)

Author keywords

ANCA; Glomerulonephritis; Hepatitis; Interferon ; Mixed cryoglobulinaemia; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNE COMPLEX DEPOSITION; PRIORITY JOURNAL; SYSTEMIC VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGEN-ANTIBODY COMPLEX; CRYOGLOBULINEMIA; FEMALE; GLOMERULONEPHRITIS; HUMANS; MIDDLE AGED; VASCULITIS;

EID: 0031962737     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.1.213     Document Type: Article

References (48)

1. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an International Conference. Arthritis Rheum 1994; 37: 187-192
2. Gross WL, Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmatic antibodies in vasculitis. Curr Opin Rheumatol 1995; 7: 11-19
3. Hagen EC, Andrassy K, Csernok E et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: a report of the first phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1993; 159: 1-16
4. Rao JK, Allen NB, Feussner JR, Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 346: 926-31
5. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995; 123: 925-932
6. Edgar JDM, McMillan SA, Bruce JN, Caulan SK. An audit of ANCA in routine clinical practice. Postgrad Med J 1995; 71: 605-612
7. Malnick SDH, Bass DD, Sthoeger ZM. C-ANCA as a marker of Wegener's disease (Letter). Lancet 1996; 347: 117-118
8. Pawlotsky J-M, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. Arch Dermatol 1995; 131: 1185-1193
9. Gumber SC, Chopra S. Hepatitis C. a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620
10. Dupin N, Chosidow O, Lunel F et al. Essential mixed cryoglobulinemia.A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol 1995; 131: 1124-1127
11. Wong VS, Egner W, Elsey T et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C infection. Clin Exp Immunol 1996; 104: 25-31
12. Katayama I, Kimura K, Nishioka K. Cold induced complement activation in hepatitis C virus associated vasculopathy. J Rheumatol 1995; 22: 1806-1807
13. Vitali C, Ferri C, Nasti P et al. Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed croglobulinemia. Br J Rheumatol 1994; 33: 791-792
14. Zignego AL, Ferri C, Giannini C et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-34
15. Fornasieri A, D'Amico G. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant 1996; 11 [Suppl. 4]: 25-30
16. D'Amico G. Is type II mixed cryoglobulinaemia an essential part of hepatitis C virus (HCV)-associated glomerulonephritis? Nephrol Dial Transplant 1995; 10: 1279-1282
17. Pasero GP, Bombardieri S, Ferri C. From internal medicine to rheumatology and back: the example of mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13: 1-5
18. Dolcher MP, Marchini B, Sabbatini A et al. Autoantibodies from mixed cryoglobulinemia patients bind glomerular antigens. Clin Exp Immunol 1994; 96: 317-322
19. Gabrielli A, Zhang Z-X, Cherubini G et al. Differential humoral immune response against hepatitis virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinemia. Clin Exp Immunol 1996; 105: 59-64
20. Monti G, Galli M, Invernezzi F et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 1995; 88: 115-126
21. Tarantino A, Campise M, Banfi G et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623
22. Cacoub P, Musset L, Lunel F et al. Hepatitis C virus and essential mixed cryoglobulinemia. Br J Rheumatol 1993; 32: 689-692
23. Lerner AB, Watson CJ. Studies of cryoglobulins. I. Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947; 214: 410-415
24. Brouet J-C, Clauvel J-P, Danon F et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-788
25. Abel G, Zhang Q-X, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993; 36: 1341-1349
26. Bloch KJ. Cryoglobulinemia and hepatitis virus. N Engl J Med 1992; 327: 1521-1522
27. Karlsberg PL, Lee WM, Casey DL et al. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia. Arch Dermatol 1995; 131: 1119-1123
28. Pasqual M, Perrin L, Giostra E et al. Hepatitis C virus in patients with cryoglogulinemia type II. J Infect Dis 1990; 162: 569-570
29. Ferri C, Greco F, Longobardo G et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606-1610
30. Agnello V, Chung RT, Kaplan LM. A role for hepatitis V virus infection in type II croglobulinemia. N Engl J Med 1992; 327: 1490-1495
31. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173
32. Sansono D, Jacobelli R, Cornacchiulo V et al. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotypic in situ hybridization in bone marrow and peripheral blood mononuclear cells of cronically HCV-infected patients. Clin Exp Immunol 1996; 103: 414-421
33. Martin P. Hepatitis C genotypes: The key to pathogenicity ? Ann Intern Med 1995; 122: 227-228
34. Sinico RA, Ribero ML, Fornasieri A et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. Q J Med 1995; 88: 805-810
35. Reinhold-Keller E, Kekow J, Schnabel A et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994; 37: 919-924
36. Gross WL. New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 1994; 6: 11-19
37. Tallar-Williams C, Hijazi Y, Walter M et al. Cyclophosphamide-induced cystitis and bladder cancer in Wegener's granulomatosis. Ann Intern Med 1996; 124: 477-484
38. DeGroot K, Reinhold-Keller E, Tatsis E et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/ sulfamethoxazole. Arthritis Rheum 1996: 39; 2052-2061
39. Sinico RA, Fornasieri A, Fiorini G et al. Plasma exchange in the treatment of essential mixed cryoglobulinemia nephropathy. Long-term follow up. Int J Artif Organs 1984; 8: 15-18
40. De Vecchi A, Montagnino G, Pozzi C et al. Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol 1983; 19: 221-227
41. Durand JM, Cretel E, Kapllanski G et al. Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection. Clin Rheumatol 1994; 13: 123-125
42. Gilli P, Stabellini N, Storari A et al. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Nephrol Dial Transplant 1996; 11: 526-528
43. Antonelli G, Gianelli G, Currenti M et al. Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-α therapy. Clin Exp Immunol 1996; 104: 384-387
44. Finter NB: The naming of cats - and alpha interferons. Lancet 1996; 348: 348-349
45. Yamabe H, Johnson RJ, Gretch DR et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-α. Am J Kidney Dis 1995; 25: 67-69
46. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125: 658-668
47. Hoofnagle JH. Di Bisceglie. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356
48. Gross WL, Hauschild S, Schmitt WH. Immundiagnostische und immunpathogenetische Bedeutung von Anti-Neutrophilen-Zytoplasma-Antikörpern. Dtsch Med Wochen Wochenschr 1993; 18: 191-199